Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Cutler

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ultrastructural Pathology|January 8, 2004
Nail-patella glomerulopathy without associated constitutional abnormalitiesCraig W Zuppan, Douglas A Weeks, Drew Cutler
Pediatric Nephrology (Berlin, Germany)|May 12, 2016
Inpatient citrate-based hemodialysis in pediatric patientsCecile Fajardo, Cheryl P Sanchez, Drew Cutler, et al.
The American Surgeon|January 9, 2003
Superior long-term results of renal transplantation in children under 5 years of ageOkechukwu Ojogho, Shobha Sahney, Drew Cutler, et al.
Pediatric Transplantation|September 3, 2011
Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipientsTimothy J Chinnock, Tamara Shankel, Douglas Deming, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 18, 2008
Developmental outcomes after pediatric heart transplantationRichard E Chinnock, M Catherin Freier, Stephen Ashwal, et al.
Pediatric Transplantation|April 17, 2013
Comparison of outcomes of hand-assisted laparoscopic to open donor nephrectomy for pediatric recipientsPedro W Baron, Jaysson Brooks, D Duane Baldwin, et al.
Pediatric Transplantation|January 12, 2008
Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: a retrospective studyPedro W Baron, Okechukwu N Ojogho, Peter Yorgin, et al.
Plos One|February 26, 2013
Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosisIzabela A Malinowska, Nancy Lee, Vidhya Kumar, et al.
Plos One|September 15, 2011
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decreaseSandra L Dabora, David Neal Franz, Stephen Ashwal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ultrastructural Pathology|January 8, 2004
Nail-patella glomerulopathy without associated constitutional abnormalitiesCraig W Zuppan, Douglas A Weeks, Drew Cutler
Pediatric Nephrology (Berlin, Germany)|May 12, 2016
Inpatient citrate-based hemodialysis in pediatric patientsCecile Fajardo, Cheryl P Sanchez, Drew Cutler, et al.
The American Surgeon|January 9, 2003
Superior long-term results of renal transplantation in children under 5 years of ageOkechukwu Ojogho, Shobha Sahney, Drew Cutler, et al.
Pediatric Transplantation|September 3, 2011
Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipientsTimothy J Chinnock, Tamara Shankel, Douglas Deming, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 18, 2008
Developmental outcomes after pediatric heart transplantationRichard E Chinnock, M Catherin Freier, Stephen Ashwal, et al.
Pediatric Transplantation|April 17, 2013
Comparison of outcomes of hand-assisted laparoscopic to open donor nephrectomy for pediatric recipientsPedro W Baron, Jaysson Brooks, D Duane Baldwin, et al.
Pediatric Transplantation|January 12, 2008
Comparison of outcomes with low-dose anti-thymocyte globulin, basiliximab or no induction therapy in pediatric kidney transplant recipients: a retrospective studyPedro W Baron, Okechukwu N Ojogho, Peter Yorgin, et al.
Plos One|February 26, 2013
Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosisIzabela A Malinowska, Nancy Lee, Vidhya Kumar, et al.
Plos One|September 15, 2011
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decreaseSandra L Dabora, David Neal Franz, Stephen Ashwal, et al.
Pageof 1